Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

1.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
1.5K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

982
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
982
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CART.

Blood immunology & cellular therapy·2026
Same author

No association of prior administration of selected vaccines with lymphoma prognosis.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

Blood cancer discovery·2026
Same author

Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.

American journal of hematology·2026
Same author

Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

Blood advances·2026
Same author

Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.

American journal of hematology·2026

相关实验视频

Updated: Jun 27, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.1K

定义初级耐火性大B细胞淋巴瘤的定义

Allison M Bock1,2, Raphael Mwangi3, Yucai Wang1

  • 1Division of Hematology, Mayo Clinic, Rochester, MN.

Blood advances
|April 26, 2024
PubMed
概括
此摘要是机器生成的。

定义初级耐火性大B细胞淋巴瘤 (LBCL) 是至关重要的. 在前线治疗期间患有进展性疾病 (PD) 的患者的生存率明显降低,这表明对初级耐火性LBCL的定义有所改进.

更多相关视频

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

11.4K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

相关实验视频

Last Updated: Jun 27, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.1K
Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

11.4K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 流行病学 流行病学

背景情况:

  • 大型B细胞淋巴瘤 (LBCL) 患者在免疫化学疗法 (IC) 后未达到完全反应或早期复发后,预后不佳.
  • 目前对初级耐火性疾病的定义各不相同,影响临床实践和研究.

研究的目的:

  • 根据复发时间来定义耐火状态的变化.
  • 评估一次性耐火性LBCL的不同定义与生存结果之间的关联.

主要方法:

  • 分析了两个独立的队列:分子流行病学资源 (MER; N=949) 和淋巴瘤流行病学结果 (LEO; N=2755).
  • 在2002年9月至2021年5月期间被诊断出新诊断的LBCL的LBCL患者.
  • 主要耐火性LBCL是由初级进展性疾病 (PPD),部分反应 (PR) 或早期复发 (CR后3-12个月) 定义的.

主要成果:

  • 与部分反应或早期复发患者相比,患有初级进展性疾病 (PPD) 的患者的整体存活率 (OS) 显著下降.
  • 在MER队列中,PPD的2年OS率为15%,PR为38%,早期复发为44%.
  • 在LEO队列中,PPD的2年OS率为31%,PR为50%,早期复发为58%.

结论:

  • 在前线IC期间经历稳定疾病 (SD) 或进展性疾病 (PD) 的患者代表了具有糟糕结果的独特子组.
  • 建议对初级耐火性LBCL进行细化定义,即在前线治疗期间或结束时将SD或PD定义为SD或PD.